Serina Therapeutics (SER) Shares Outstanding (2017 - 2026)

Serina Therapeutics has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $10.8 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 46.31% year-over-year to $10.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.8 million (up 46.31% YoY) and the FY2025 annual result came in at $10.8 million, up 46.31% from the prior year.
• Shares Outstanding (Entity) advanced to $10.8 million in Q4 2025 per SER's latest filing, from $10.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $10.8 million in Q4 2025 and troughed at $1079.0 in Q2 2022.
• A 5-year average of $3.5 million and a median of $1.1 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) slumped 99.9% in 2023, then jumped 823996.39% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $1.1 million in 2021, then increased by 0.01% to $1.1 million in 2022, then slumped by 99.9% to $1079.0 in 2023, then soared by 681920.39% to $7.4 million in 2024, then soared by 46.31% to $10.8 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $10.8 million, $10.5 million, and $10.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.